[Federal Register: December 2, 2003 (Volume 68, Number 231)]
[Notices]
[Page 67473-67474]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02de03-93]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated August 19, 2003, and published in the Federal
Register on September 2, 2003, (68 FR 52224), Cambrex Charles City,
Inc., 1205 11th Street, Charles City, Iowa 50616, made application by
letter to the Drug Enforcement Administration for registration as a
bulk manufacturer of Dextropropoxyphene (9273), a basic class of
Schedule II controlled substance.
The firm plans to manufacture bulk controlled substances for
distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in title 21, United States Code, section 823(a) and
determined that the regulation of Cambrex Charles City, Inc. to
manufacture the listed controlled substance is consistent with the
public interest at this time. DEA has investigated Cambrex Charles
City, Inc. to ensure that the company's registration is consistent with
the public interest. This investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state
[[Page 67474]]
and local laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the
Deputy Assistant Administrator, Office of Diversion Control, hereby
orders that the application submitted by the above firm for
registration as a bulk manufacturer of the basic class of controlled
substance listed is granted.
Dated: November 19, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 03-29974 Filed 12-1-03; 8:45 am]
BILLING CODE 4410-09-M